Published in Psychol Rep on August 01, 2008
A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet (2002) 3.52
Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry (2009) 2.74
Security and psychiatry: the British experience and implications for forensic psychiatry services in Israel. Isr Med Assoc J (2010) 2.02
Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry (2004) 1.86
Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc Natl Acad Sci U S A (2007) 1.85
Renal insufficiency in long-term lithium treatment. J Clin Psychiatry (2004) 1.77
Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nat Struct Mol Biol (2008) 1.64
Efficient vaccine against the virus causing a lethal disease in cultured Cyprinus carpio. Vaccine (2003) 1.64
An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model. J Mol Biol (2009) 1.62
Psychiatric admissions and hospitalization in Israel: an epidemiologic study of where we stand today and where we are going. Isr Med Assoc J (2005) 1.55
Effect of acute psychotic stress in nondiabetic subjects on beta-cell function and insulin sensitivity. Diabetes Care (2003) 1.53
Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr Med Assoc J (2005) 1.52
Pathological gambling: an impulse control disorder? Measurement of impulsivity using neurocognitive tests. Isr Med Assoc J (2010) 1.46
Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Clin Neuropharmacol (2013) 1.39
Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine. J Clin Psychopharmacol (2016) 1.39
Pathogenesis of acute viral disease induced in fish by carp interstitial nephritis and gill necrosis virus. J Virol (2004) 1.36
Detection of carp interstitial nephritis and gill necrosis virus in fish droppings. Appl Environ Microbiol (2005) 1.24
Catalytic beacons for the detection of DNA and telomerase activity. J Am Chem Soc (2004) 1.21
Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol Psychiatry (2004) 1.18
APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. Blood (2012) 1.15
Go-no-go performance in pathological gamblers. Psychiatry Res (2008) 1.15
COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2004) 1.15
Spotlighting of cocaine by an autonomous aptamer-based machine. J Am Chem Soc (2007) 1.11
Protection of cultured Cyprinus carpio against a lethal viral disease by an attenuated virus vaccine. Vaccine (2005) 1.11
Antisemitism and the history of medicine: the challenge then and now. Isr Med Assoc J (2010) 1.08
Persistence of cyprinid herpesvirus 3 in infected cultured carp cells. J Virol (2007) 1.08
Description of an as yet unclassified DNA virus from diseased Cyprinus carpio species. J Virol (2005) 1.08
Lenin's malady. Hum Pathol (2013) 1.07
Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol (2004) 1.05
Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response. Int J Neuropsychopharmacol (2007) 1.05
Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. Am J Psychiatry (2002) 1.03
Reduced language lateralization in first-episode schizophrenia: an fMRI index of functional asymmetry. Psychiatry Res (2009) 1.02
Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophr Res (2003) 1.02
A virus spotlighted by an autonomous DNA machine. Angew Chem Int Ed Engl (2006) 1.00
Global functional connectivity deficits in schizophrenia depend on behavioral state. J Neurosci (2011) 0.99
Amplified chemiluminescence surface detection of DNA and telomerase activity using catalytic nucleic acid labels. Anal Chem (2004) 0.98
Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affect Disord (2010) 0.97
Psychiatric genocide: reflections and responsibilities. Schizophr Bull (2010) 0.97
Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol (2005) 0.97
Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. J Clin Psychopharmacol (2005) 0.96
Characterization of a novel virus causing a lethal disease in carp and koi. Microbiol Mol Biol Rev (2006) 0.95
Three year naturalistic outcome study of panic disorder patients treated with paroxetine. BMC Psychiatry (2004) 0.95
Comorbid cannabis use and panic disorder: short term and long term follow-up study. Hum Psychopharmacol (2004) 0.94
Demographic and clinical characteristics of motor vehicle accident victims in the community general health outpatient clinic: a comparison of PTSD and non-PTSD subjects. Depress Anxiety (2007) 0.94
Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides. J Biol Chem (2007) 0.94
Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J (2004) 0.93
Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol (2002) 0.93
Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimul (2009) 0.93
Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif. J Mol Biol (2011) 0.93
Amantadine as augmentation therapy in the management of treatment-resistant depression. Int Clin Psychopharmacol (2003) 0.93
Impaired heart rate variability in euthymic bipolar patients. Bipolar Disord (2003) 0.93
APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. Cancer Res (2013) 0.92
12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. J Clin Psychopharmacol (2007) 0.92
Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J Clin Psychiatry (2010) 0.92
MOR: a simulation-based assessment centre for evaluating the personal and interpersonal qualities of medical school candidates. Med Educ (2008) 0.92
Shared obsessive-compulsive disorder: broadening the concept of shared psychotic disorder. Aust N Z J Psychiatry (2010) 0.92
Deep transcranial magnetic stimulation for the treatment of auditory hallucinations: a preliminary open-label study. Ann Gen Psychiatry (2011) 0.91
Cyprinid herpes virus-3 (CyHV-3) bears genes of genetically distant large DNA viruses. FEBS Lett (2006) 0.91
Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. J Clin Psychiatry (2008) 0.90
Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry (2003) 0.88
Segmental dystonia as the sole manifestation of carbamazepine toxicity. Gen Hosp Psychiatry (2002) 0.88
The immediate early gene Arc is associated with behavioral resilience to stress exposure in an animal model of posttraumatic stress disorder. Eur Neuropsychopharmacol (2007) 0.88
Coordinated and sequential transcription of the cyprinid herpesvirus-3 annotated genes. Virus Res (2012) 0.88
Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia. Neurosci Lett (2005) 0.88
Social phobia symptoms: prevalence, sociodemographic correlates, and overlap with specific phobia symptoms. Compr Psychiatry (2006) 0.88
Pathological gambling: an update on neuropathophysiology and pharmacotherapy. CNS Drugs (2008) 0.88
Risk-taking decisions in pathological gamblers is not a result of their impaired inhibition ability. Psychiatry Res (2011) 0.88
A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder. Clin Neuropharmacol (2007) 0.87
Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology. Schizophr Res (2004) 0.87
The hateful patient revisited: Relevance for 21st century medicine. Eur J Intern Med (2006) 0.87
Finding the hidden faces: schizophrenic patients fare worse than healthy subjects. Neuropsychologia (2008) 0.86
The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes. FASEB J (2003) 0.86
Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease. Clin Neuropharmacol (2002) 0.86
[Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs]. Harefuah (2011) 0.86
Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.86
Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study. J Clin Psychiatry (2002) 0.86
Stroop performance in pathological gamblers. Psychiatry Res (2006) 0.86
Antibody response and resistance of Cyprinus carpio immunized with cyprinid herpes virus 3 (CyHV-3). Vaccine (2008) 0.86
Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorder. Prim Care Companion J Clin Psychiatry (2006) 0.85
The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients. Int J Geriatr Psychiatry (2004) 0.85
Dual psychiatric diagnosis and substance abuse in pathological gamblers: a preliminary gender comparison study. J Addict Dis (2006) 0.85
Treatment of eating disorders improves eating symptoms but not alexithymia and dissociation proneness. Compr Psychiatry (2006) 0.84
Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study. Clin Neuropharmacol (2009) 0.84
Quetiapine: efficacy, tolerability and safety in schizophrenia. Expert Rev Neurother (2006) 0.84
Deep transcranial magnetic stimulation add-on for the treatment of auditory hallucinations: a double-blind study. Ann Gen Psychiatry (2012) 0.84
Biosensing and probing of intracellular metabolic pathways by NADH-sensitive quantum dots. Angew Chem Int Ed Engl (2009) 0.84
The Positive and Negative Symptoms Questionnaire: a self-report scale in schizophrenia. Compr Psychiatry (2005) 0.84
Sodium dodecyl sulphate-treated proteins as ligands in ELISA. J Immunol Methods (2002) 0.84
Hemisphere asymmetry in schizophrenia as revealed through line bisection, line trisection, and letter cancellation. Brain Res (2007) 0.84
Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study. Hum Psychopharmacol (2004) 0.84
Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders. J Clin Psychiatry (2005) 0.83
Neuropsychological mechanisms of Digit Symbol Substitution Test impairment in Asperger Disorder. Psychiatry Res (2009) 0.83
Stroop performance in major depression: selective attention impairment or psychomotor slowness? J Affect Disord (2009) 0.83